
Jake Minh Vu
Examiner (ID: 14384, Phone: (571)272-8148 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1094 |
| Issued Applications | 353 |
| Pending Applications | 146 |
| Abandoned Applications | 625 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16555834
[patent_doc_number] => 20210000982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => HYDROGEL COMPRISING MANGANESE, METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/956916
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16956916
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/956916 | HYDROGEL COMPRISING MANGANESE, METHODS AND USES THEREOF | Dec 20, 2018 | Abandoned |
Array
(
[id] => 14210891
[patent_doc_number] => 20190117830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => IMPLANTABLE EMBOLIC SCAFFOLDS
[patent_app_type] => utility
[patent_app_number] => 16/221224
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16221224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/221224 | IMPLANTABLE EMBOLIC SCAFFOLDS | Dec 13, 2018 | Abandoned |
Array
(
[id] => 17426943
[patent_doc_number] => 20220054651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => TERNARY MICELLAR COMPLEX COMPOSED OF A SIALOGLYCOSPHINGOLIPID, A THERAPEUTICALLY ACTIVE SUBSTANCE AND AN ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 17/413923
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17413923
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/413923 | TERNARY MICELLAR COMPLEX COMPOSED OF A SIALOGLYCOSPHINGOLIPID, A THERAPEUTICALLY ACTIVE SUBSTANCE AND AN ANTIBODY | Dec 13, 2018 | Abandoned |
Array
(
[id] => 14098957
[patent_doc_number] => 20190091154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES
[patent_app_type] => utility
[patent_app_number] => 16/210278
[patent_app_country] => US
[patent_app_date] => 2018-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16210278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/210278 | HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES | Dec 4, 2018 | Abandoned |
Array
(
[id] => 16868625
[patent_doc_number] => 20210162092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => MEDICAL HYDROGEL
[patent_app_type] => utility
[patent_app_number] => 17/267788
[patent_app_country] => US
[patent_app_date] => 2018-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267788
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267788 | MEDICAL HYDROGEL | Oct 22, 2018 | Abandoned |
Array
(
[id] => 16221368
[patent_doc_number] => 20200246484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => SPHERICAL NUCLEIC ACIDS (SNAS) WITH SHEDDABLE PEG LAYERS
[patent_app_type] => utility
[patent_app_number] => 16/753269
[patent_app_country] => US
[patent_app_date] => 2018-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16753269
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/753269 | SPHERICAL NUCLEIC ACIDS (SNAS) WITH SHEDDABLE PEG LAYERS | Oct 2, 2018 | Pending |
Array
(
[id] => 16236631
[patent_doc_number] => 20200253865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => Supraparticles
[patent_app_type] => utility
[patent_app_number] => 16/648858
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648858 | Supraparticles | Sep 19, 2018 | Abandoned |
Array
(
[id] => 13790417
[patent_doc_number] => 20190008747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/130207
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16130207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/130207 | EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME | Sep 12, 2018 | Abandoned |
Array
(
[id] => 14016651
[patent_doc_number] => 20190070319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => SILICONE-BASED ENTERIC CT CONTRAST MATERIAL
[patent_app_type] => utility
[patent_app_number] => 16/126844
[patent_app_country] => US
[patent_app_date] => 2018-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16126844
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/126844 | SILICONE-BASED ENTERIC CT CONTRAST MATERIAL | Sep 9, 2018 | Abandoned |
Array
(
[id] => 16539443
[patent_doc_number] => 20200405856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => SONO-RESPONSIVE EMBOLIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/644142
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644142 | SONO-RESPONSIVE EMBOLIC AGENTS | Sep 6, 2018 | Pending |
Array
(
[id] => 16539443
[patent_doc_number] => 20200405856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => SONO-RESPONSIVE EMBOLIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/644142
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644142 | SONO-RESPONSIVE EMBOLIC AGENTS | Sep 6, 2018 | Pending |
Array
(
[id] => 16058275
[patent_doc_number] => 10688059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Multiparticulate L-carnitine compositions and related methods
[patent_app_type] => utility
[patent_app_number] => 16/121245
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3967
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16121245
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/121245 | Multiparticulate L-carnitine compositions and related methods | Sep 3, 2018 | Issued |
Array
(
[id] => 16686876
[patent_doc_number] => 20210069351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => METHOD FOR SCREENING PAIN INHIBITING SUBSTANCE
[patent_app_type] => utility
[patent_app_number] => 16/763194
[patent_app_country] => US
[patent_app_date] => 2018-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763194
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/763194 | METHOD FOR SCREENING PAIN INHIBITING SUBSTANCE | Aug 22, 2018 | Abandoned |
Array
(
[id] => 16883861
[patent_doc_number] => 20210170056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => SLIPPERY MICROPROPELLERS PENETRATE THE VITREOUS HUMOR
[patent_app_type] => utility
[patent_app_number] => 16/641059
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16641059
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/641059 | SLIPPERY MICROPROPELLERS PENETRATE THE VITREOUS HUMOR | Aug 20, 2018 | Pending |
Array
(
[id] => 17080684
[patent_doc_number] => 20210275690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => UV-DETECTABLE ANTIMICROBIAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/339391
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/339391 | UV-DETECTABLE ANTIMICROBIAL COMPOSITION | Aug 8, 2018 | Abandoned |
Array
(
[id] => 20188015
[patent_doc_number] => 12399124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Ultra-sensitive detection method using photoluminescent particles
[patent_app_type] => utility
[patent_app_number] => 16/635515
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 34
[patent_no_of_words] => 18965
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 400
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635515
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635515 | Ultra-sensitive detection method using photoluminescent particles | Aug 2, 2018 | Issued |
Array
(
[id] => 15960267
[patent_doc_number] => 20200163885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => COMPOSITION FOR DELIVERING PHYSIOLOGICALLY ACTIVE INGREDIENTS INTO BLOOD VESSEL
[patent_app_type] => utility
[patent_app_number] => 16/633849
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633849 | COMPOSITION FOR DELIVERING PHYSIOLOGICALLY ACTIVE INGREDIENTS INTO BLOOD VESSEL | Jul 24, 2018 | Pending |
Array
(
[id] => 15960267
[patent_doc_number] => 20200163885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => COMPOSITION FOR DELIVERING PHYSIOLOGICALLY ACTIVE INGREDIENTS INTO BLOOD VESSEL
[patent_app_type] => utility
[patent_app_number] => 16/633849
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633849 | COMPOSITION FOR DELIVERING PHYSIOLOGICALLY ACTIVE INGREDIENTS INTO BLOOD VESSEL | Jul 24, 2018 | Pending |
Array
(
[id] => 16718556
[patent_doc_number] => 20210085703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => Compositions and Methods for Preventing or Treating Nephrolithiasis
[patent_app_type] => utility
[patent_app_number] => 16/630617
[patent_app_country] => US
[patent_app_date] => 2018-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/630617 | Compositions and Methods for Preventing or Treating Nephrolithiasis | Jul 9, 2018 | Abandoned |
Array
(
[id] => 17028482
[patent_doc_number] => 11090280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Liquid dosage forms of sodium naproxen
[patent_app_type] => utility
[patent_app_number] => 16/012961
[patent_app_country] => US
[patent_app_date] => 2018-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3944
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16012961
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/012961 | Liquid dosage forms of sodium naproxen | Jun 19, 2018 | Issued |